Berberine might block colorectal carcinogenesis by inhibiting the regulation of B-cell function by Veillonella parvula

Yun QIAN; Ziran KANG; Licong ZHAO; Huimin CHEN; Chengbei ZHOU; Qinyan GAO; Zheng WANG; Qiang LIU; Yun CUI; Xiaobo LI; Yingxuan CHEN; Tianhui ZOU; Jingyuan FANG.
Chinese Medical Journal ; (24): 2722-2731, 2023.
Artículo en Inglés | WPRIM | ID: wpr-1007642

Documentos relacionados

  1. Berberine might block colorectal carcinogenesis by inhibiting the regulation of B-cell function by Veillonella parvula.
  2. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
  3. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine.
  4. Elucidating the role of T-cell exhaustion-related genes in colorectal cancer: a single-cell bioinformatics perspective.
  5. Integration of bulk RNA sequencing data and single-cell RNA sequencing analysis on the heterogeneity in patients with colorectal cancer.
  6. KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis.
  7. Discovery of the oncogenic MDM2, a direct binding target of berberine and a potential therapeutic, in multiple myeloma.
  8. Identification of potential functional variants and genes at 18q21.1 associated with the carcinogenesis of colorectal cancer.
  9. Berberine Induces Combined Cell Death in Gastrointestinal Cell Lines.
  10. [Berberine alleviates programmed necrosis of metabolic-associated fatty liver disease via activating Nrf2 pathway in mice].